Bacterial endophthalmitis in the age of outpatient intravitreal therapies and cataract surgeries: Host-microbe interactions in intraocular infection

Progress in Retinal and Eye Research

Volumn 31, Issue 4, 2012, Pages 316-331

  Sadaka, Ama ^a,b   Durand, Marlene L ^c   Gilmore, Michael S ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Bacillus; Coagulase negative staphylococci; Endophthalmitis; Enterococcus faecalis; Staphylococcus aureus; Streptococcus pneumoniae

Indexed keywords

CYTOLYSIN; GAMMA INTERFERON; HOST FACTOR; INTERLEUKIN 1; INTERLEUKIN 1BETA; NITRIC OXIDE; PROTEIN A; PROTEINASE; REACTIVE OXYGEN METABOLITE; TOLL LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR ALPHA; VIRULENCE FACTOR;

ANTERIOR EYE CHAMBER; ANTIBIOTIC PROPHYLAXIS; BACILLUS CEREUS; BACTERIAL CELL WALL; BACTERIAL ENDOPHTHALMITIS; BACTERIAL VIRULENCE; CATARACT EXTRACTION; CELL DENSITY; CELL SURFACE; CYTOTOXIC T LYMPHOCYTE; DISEASE SEVERITY; ENDOPHTHALMITIS; ENTEROCOCCUS FAECALIS; EYE INFECTION; GENE EXPRESSION; HOST PATHOGEN INTERACTION; HUMAN; IMMUNE RESPONSE; LYMPHOCYTE PROLIFERATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; OUTPATIENT; PATHOGENESIS; PATHOGENICITY; PENICILLIN RESISTANCE; PHAGOCYTOSIS; POSTERIOR EYE SEGMENT; PRIORITY JOURNAL; QUORUM SENSING; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STREPTOCOCCUS PNEUMONIA; STRESS; TREATMENT OUTCOME; UPREGULATION;

ANTI-BACTERIAL AGENTS; CATARACT EXTRACTION; ENDOPHTHALMITIS; EYE INFECTIONS, BACTERIAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTRAVITREAL INJECTIONS; STEROIDS;

EID: 84861459508     PISSN: 13509462     EISSN: 18731635     Source Type: Journal    
DOI: 10.1016/j.preteyeres.2012.03.004     Document Type: Review

References (252)

1. Albrecht E., Richards J.C., Pollock T., Cook C., Myers L. Adjunctive use of intravitreal dexamethasone in presumed bacterial endophthalmitis: a randomised trial. Br. J. Ophthalmol. 2011, 95:1385-1388.
2. Allegretti M., Moriconi A., Beccari A.R., Di Bitondo R., Bizzarri C., Bertini R., Colotta F. Targeting C5a: recent advances in drug discovery. Curr. Med. Chem. 2005, 12:217-236.
3. Allensworth J.J., Planck S.R., Rosenbaum J.T., Rosenzweig H.L. Investigation of the differential potentials of TLR agonists to elicit uveitis in mice. J. Leukoc. Biol. 2011, 90:1159-1166.
4. American Academy of Ophthalmology Cataract and Anterior segment Panel Preferred Practice Pattern Guidelines. Cataract in the Adult Eye 2011, American Academy of Ophthalmology, San Francisco, CA, Available at:. http://www.aao.org/ppp.
5. Anand A.R., Therese K.L., Madhavan H.N. Spectrum of aetiological agents of postoperative endophthalmitis and antibiotic susceptibility of bacterial isolates. Indian J. Ophthalmol. 2000, 48:123-128.
6. Asbell P.A., Sahm D.F., Shaw M., Draghi D.C., Brown N.P. Increasing prevalence of methicillin resistance in serious ocular infections caused by Staphylococcus aureus in the United States: 2000 to 2005. J. Cataract Refract. Surg. 2008, 34:814-818.
7. Asbell P.A., Colby K.A., Deng S., McDonnell P., Meisler D.M., Raizman M.B., Sheppard J.D., Sahm D.F. Ocular TRUST: nationwide antimicrobial susceptibility patterns in ocular isolates. Am. J. Ophthalmol. 2008, 145:951-958.
8. Baillif S., Ecochard R., Casoli E., Freney J., Burillon C., Kodjikian L. Adherence and kinetics of biofilm formation of Staphylococcus epidermidis to different types of intraocular lenses under dynamic flow conditions. J. Cataract Refract. Surg. 2008, 34:153-158.
9. Bainbridge J.W., Teimory M., Tabandeh H., Kirwan J.F., Dalton R., Reid F., Rostron C.K. Intraocular lens implants and risk of endophthalmitis. Br. J. Ophthalmol. 1998, 82:1312-1315.
10. Barbier F. Methicillin-resistant coagulase-negative staphylococci in the community: high homology of SCCmec IVa between Staphylococcus epidermidis and major clones of methicillin-resistant Staphylococcus aureus. J. Infect. Dis. 2010, 202:270-281.
11. Barrett A.J., Rawlings N.D., Woessner J.F. Handbook of Proteolytic Enzymes 1998, 350-369 p.
12. Bausz M., Fodor E., Resch M.D., Kristof K. Bacterial contamination in the anterior chamber after povidone-iodine application and the effect of the lens implantation device. J. Cataract Refract. Surg. 2006, 32:1691-1695.
13. Bazzoni F., Beutler B. The tumor necrosis factor ligand and receptor families. N. Engl. J. Med. 1996, 334:1717-1725.
14. Beenken K.E., Mrak L.N., Griffin L.M., Zielinska A.K., Shaw L.N., Rice K.C., Horswill A.R., Bayles K.W., Smeltzer M.S. Epistatic relationships between sarA and agr in Staphylococcus aureus biofilm formation. PLoS One 2010, 5:e10790.
15. Bekeredjian-Ding I., Inamura S., Giese T., Moll H., Endres S., Sing A., Zahringer U., Hartmann G. Staphylococcus aureus protein A triggers T cell-independent B cell proliferation by sensitizing B cells for TLR2 ligands. J. Immunol. 2007, 178:2803-2812.
16. Bera A., Biswas R., Herbert S., Kulauzovic E., Weidenmaier C., Peschel A., Gotz F. Influence of wall teichoic acid on lysozyme resistance in Staphylococcus aureus. J. Bacteriol. 2007, 189:280-283.
17. Beveridge T.J., Makin S.A., Kadurugamuwa J.L., Li Z. Interactions between biofilms and the environment. FEMS Microbiol. Rev. 1997, 20:291-303.
18. Beyer T.L., Vogler G., Sharma D., O'Donnell F.E. Protective barrier effect of the posterior lens capsule in exogenous bacterial endophthalmitis - an experimental primate study. Invest. Ophthalmol. Vis. Sci. 1984, 25:108-112.
19. Bischoff M., Dunman P., Kormanec J., Macapagal D., Murphy E., Mounts W., Berger-Bachi B., Projan S. Microarray-based analysis of the Staphylococcus aureus sigmaB regulon. J. Bacteriol. 2004, 186:4085-4099.
20. Blum-Hareuveni T., Rehany U., Rumelt S. Devastating endophthalmitis following penetrating ocular injury during night sleep from orthodontic headgear: case report and literature review. Graefes Arch. Clin. Exp. Ophthalmol. 2006, 244:253-258.
21. Boles B.R., Horswill A.R. Staphylococcal biofilm disassembly. Trends Microbiol. 2011.
22. Booth M.C., Atkuri R.V., Nanda S.K., Iandolo J.J., Gilmore M.S. Accessory gene regulator controls Staphylococcus aureus virulence in endophthalmitis. Invest. Ophthalmol. Vis. Sci. 1995, 36:1828-1836.
23. Booth M.C., Cheung A.L., Hatter K.L., Jett B.D., Callegan M.C., Gilmore M.S. Staphylococcal accessory regulator (sar) in conjunction with agr contributes to Staphylococcus aureus virulence in endophthalmitis. Infect. Immun. 1997, 65:1550-1556.
24. Brandl K., Plitas G., Mihu C.N., Ubeda C., Jia T., Fleisher M., Schnabl B., DeMatteo R.P., Pamer E.G. Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits. Nature 2008, 455:804-807.
25. Brian G., Taylor H. Cataract blindness-challenges for the 21st century. Bull. World Health Organ. 2001, 79:249-256.
26. Bucher R.S., Hall E., Reed D.M., Richards J.E., Johnson M.W., Zacks D.N. Effect of intravitreal triamcinolone acetonide on susceptibility to experimental bacterial endophthalmitis and subsequent response to treatment. Arch. Ophthalmol. 2005, 123:649-653.
27. Bunschoten A., Ippel J.H., Kruijtzer J.A., Feitsma L., de Haas C.J., Liskamp R.M., Kemmink J. A peptide mimic of the chemotaxis inhibitory protein of Staphylococcus aureus: towards the development of novel anti-inflammatory compounds. Amino Acids 2011, 40:731-740.
28. Caiazza N.C., O'Toole G.A. Alpha-toxin is required for biofilm formation by Staphylococcus aureus. J. Bacteriol. 2003, 185:3214-3217.
29. Callegan M.C., Booth M.C., Jett B.D., Gilmore M.S. Pathogenesis of gram-positive bacterial endophthalmitis. Infect. Immun. 1999, 67:3348-3356.
30. Callegan M.C., Jett B.D., Hancock L.E., Gilmore M.S. Role of hemolysin BL in the pathogenesis of extraintestinal Bacillus cereus infection assessed in an endophthalmitis model. Infect. Immun. 1999, 67:3357-3366.
31. Callegan M.C., Kane S.T., Cochran D.C., Gilmore M.S. Molecular mechanisms of Bacillus endophthalmitis pathogenesis. DNA Cell Biol. 2002, 21:367-373.
32. Callegan M.C., Engelbert M., Parke D.W., Jett B.D., Gilmore M.S. Bacterial endophthalmitis: epidemiology, therapeutics, and bacterium-host interactions. Clin. Microbiol. Rev. 2002, 15:111-124.
33. Callegan M.C., Cochran D.C., Kane S.T., Gilmore M.S., Gominet M., Lereclus D. Contribution of membrane-damaging toxins to Bacillus endophthalmitis pathogenesis. Infect. Immun. 2002, 70:5381-5389.
34. Callegan M.C., Kane S.T., Cochran D.C., Gilmore M.S., Gominet M., Lereclus D. Relationship of plcR-regulated factors to Bacillus endophthalmitis virulence. Infect. Immun. 2003, 71:3116-3124.
35. Callegan M.C., Kane S.T., Cochran D.C., Novosad B., Gilmore M.S., Gominet M., Lereclus D. Bacillus endophthalmitis: roles of bacterial toxins and motility during infection. Invest. Ophthalmol. Vis. Sci. 2005, 46:3233-3238.
36. Callegan M.C., Novosad B.D., Ramirez R., Ghelardi E., Senesi S. Role of swarming migration in the pathogenesis of Bacillus endophthalmitis. Invest. Ophthalmol. Vis. Sci. 2006, 47:4461-4467.
37. Camargo I.L., Gilmore M.S. Staphylococcus aureus - probing for host weakness?. J. Bacteriol. 2008, 190:2253-2256.
38. Cardillo J.A., Paganelli F., Melo L.A., Silva A.A., Pizzolitto A.C., Oliveira A.G. Subconjunctival delivery of antibiotics in a controlled-release system: a novel anti-infective prophylaxis approach for cataract surgery. Arch. Ophthalmol. 2010, 128:81-87. Brazilian Ocular Pharmacology and Pharmaceutical Technology Research Group.
39. Cash H.L., Whitham C.V., Behrendt C.L., Hooper L.V. Symbiotic bacteria direct expression of an intestinal bactericidal lectin. Science 2006, 313:1126-1130.
40. Cavuoto K., Zutshi D., Karp C.L., Miller D., Feuer W. Update on bacterial conjunctivitis in South Florida. Ophthalmology 2008, 115:51-56.
41. Cedergren L., Andersson R., Jansson B., Uhlen M., Nilsson B. Mutational analysis of the interaction between staphylococcal protein A and human IgG1. Protein Eng. 1993, 6:441-448.
42. Centers for Disease Control and Prevention (CDC) Staphylococcus aureus resistant to vancomycin-United States, 2002. MMWR Morb. Mortal. Wkly. Rep. 2002, 51:565-567. Available at:. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5126a1.htm.
43. Chambers H.F. Methicillin resistance in staphylococci: molecular and biochemical basis and clinical implications. Clin. Microbiol. Rev. 1997, 10:781-791.
44. Chang J.H., McCluskey P.J., Wakefield D. Toll-like receptors in ocular immunity and the immunopathogenesis of inflammatory eye disease. Br. J. Ophthalmol. 2006, 90:103-108.
45. Chang D.F., Braga-Mele R., Mamalis N., Masket S., Miller K.M., Nichamin L.D., Packard R.B., Packer M., ASCRS Cataract Clinical Committee Prophylaxis of postoperative endophthalmitis after cataract surgery: results of the 2007 ASCRS member survey. J. Cataract Refract. Surg. 2007, 33:1801-1805.
46. Chen E., Lin M.Y., Cox J., Brown D.M. Endophthalmitis after intravitreal injection: the importance of viridans streptococci. Retina 2011, 31:1525-1533.
47. Cheng A.G., DeDent A.C., Schneewind O., Missiakas D. A play in four acts: Staphylococcus aureus abscess formation. Trends Microbiol. 2011, 19:225-232.
48. Chhabra S., Kunimoto D.Y., Kazi L., Regillo C.D., Ho A.C., Belmont J., Maguire J., Vander J., Brown G.C. Endophthalmitis after open globe injury: microbiologic spectrum and susceptibilities of isolates. Am. J. Ophthalmol. 2006, 142:852-854.
49. Chien Y., Manna A.C., Projan S.J., Cheung A.L. SarA, a global regulator of virulence determinants in Staphylococcus aureus, binds to a conserved motif essential for sar-dependent gene regulation. J. Biol. Chem. 1999, 274:37169-37176.
50. Coburn P.S., Pillar C.M., Jett B.D., Haas W., Gilmore M.S. Enterococcus faecalis senses target cells and in response expresses cytolysin. Science 2004, 306:2270-2272.
51. Corbin B.D. Metal chelation and inhibition of bacterial growth in tissue abscesses. Science 2008, 319:962-965.
52. Cramton S.E., Ulrich M., Gotz F., Doring G. Anaerobic conditions induce expression of polysaccharide intercellular adhesin in Staphylococcus aureus and Staphylococcus epidermidis. Infect. Immun. 2001, 69:4079-4085.
53. Crane I.J., Liversidge J. Mechanisms of leukocyte migration across the blood-retina barrier. Semin. Immunopathol. 2008, 30:165-177.
54. Das T., Jalali S., Gothwal V.K., Sharma S., Naduvilath T.J. Intravitreal dexamethasone in exogenous bacterial endophthalmitis: results of a prospective randomised study. Br. J. Ophthalmol. 1999, 83:1050-1055.
55. David D.B., Kirkby G.R., Noble B.A. Bacillus cereus endophthalmitis. Br. J. Ophthalmol. 1994, 78:577-580.
56. De Beer D., Srinivasan R., Stewart P.S. Direct measurement of chlorine penetration into biofilms during disinfection. Appl. Environ. Microbiol. 1994, 60:4339-4344.
57. De Gans J., van de Beek D., European Dexamethasone In Adulthood Bacterial Meningitis Study Investigators Dexamethasone in adults with bacterial meningitis. N. Engl. J. Med. 2002, 347:1549-1556.
58. De Kaspar H.M., Ta C.N., Engelbert M., Mette M., Thiel M., Kampik A. Effects of intravitreal corticosteroid in the treatment of Staphylococcus aureus-induced experimental endophthalmitis. Retina 2008, 28:326-332.
59. De Lencastre H., Wu S.W., Pinho M.G., Ludovice A.M., Filipe S., Gardete S., Sobral R., Gill S., Chung M., Tomasz A. Antibiotic resistance as a stress response: complete sequencing of a large number of chromosomal loci in Staphylococcus aureus strain COL that impact on the expression of resistance to methicillin. Microb. Drug Resist. 1999, 5:163-175.
60. Deramo V.A., Lai J.C., Winokur J., Luchs J., Udell I.J. Visual outcome and bacterial sensitivity after methicillin-resistant Staphylococcus aureus-associated acute endophthalmitis. Am. J. Ophthalmol. 2008, 145:413-417.
61. Diago T., McCannel C.A., Bakri S.J., Pulido J.S., Edwards A.O., Pach J.M. Infectious endophthalmitis after intravitreal injection of antiangiogenic agents. Retina 2009, 29:601-605.
62. Dickey J.B., Thompson K.D., Jay W.M. Anterior chamber aspirate cultures after uncomplicated cataract surgery. Am. J. Ophthalmol. 1991, 112:278-282.
63. Diep B.A. Complete genome sequence of USA300, an epidemic clone of community-acquired meticillin-resistant Staphylococcus aureus. Lancet 2006, 367:731-739.
64. Dunman P.M., Murphy E., Haney S., Palacios D., Tucker-Kellogg G., Wu S., Brown E.L., Zagursky R.J., Shlaes D., Projan S.J. Transcription profiling-based identification of Staphylococcus aureus genes regulated by the agr and/or sarA loci. J. Bacteriol. 2001, 183:7341-7353.
65. Endophthalmitis Study Group, European Society of Cataract & Refractive Surgeons Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factors. J. Cataract Refract. Surg. 2007, 33:978-988.
66. Engelbert M., Gilmore M.S. Fas ligand but not complement is critical for control of experimental Staphylococcus aureus Endophthalmitis. Invest. Ophthalmol. Vis. Sci. 2005, 46:2479-2486.
67. Engelbert M., Mylonakis E., Ausubel F.M., Calderwood S.B., Gilmore M.S. Contribution of gelatinase, serine protease, and fsr to the pathogenesis of Enterococcus faecalis endophthalmitis. Infect. Immun. 2004, 72:3628-3633.
68. Ermis S.S., Cetinkaya Z., Kiyici H., Ozturk F. Treatment of Staphylococcus epidermidis endophthalmitis with intravitreal moxifloxacin in a rabbit model. Tohoku J. Exp. Med. 2005, 205:223-229.
69. Ermis S.S., Cetinkaya Z., Kiyici H., Inan U.U., Ozturk F. Effects of intravitreal moxifloxacin and dexamethasone in experimental Staphylococcus aureus endophthalmitis. Curr. Eye Res. 2007, 32:337-344.
70. EVS Microbiologic factors and visual outcome in the endophthalmitis vitrectomy study. Am. J. Ophthalmol. 1996, 122:830-846.
71. Ferguson A.W., Scott J.A., McGavigan J., Elton R.A., McLean J., Schmidt U., Kelkar R., Dhillon B. Comparison of 5% povidone-iodine solution against 1% povidone-iodine solution in preoperative cataract surgery antisepsis: a prospective randomised double blind study. Br. J. Ophthalmol. 2003, 87:163-167.
72. Finks J., Wells E., Dyke T.L., Husain N., Plizga L., Heddurshetti R., Wilkins M., Rudrik J., Hageman J., Patel J., Miller C. Vancomycin-resistant Staphylococcus aureus, Michigan, USA, 2007. Emerg. Infect. Dis. 2009, 15:943-945.
73. Friswell M., Campbell B., Rhodes J. The role of bacteria in the pathogenesis of inflammatory bowel disease. Gut Liver 2010, 4:295-306.
74. Fukuda M., Ohashi H., Matsumoto C., Mishima S., Shimomura Y. Methicillin-resistant Staphylococcus aureus and methicillin-resistant coagulase-negative Staphylococcus ocular surface infection efficacy of chloramphenicol eye drops. Cornea 2002, 21:S86-S89.
75. Gan I.M., Ugahary L.C., van Dissel J.T., van Meurs J.C. Effect of intravitreal dexamethasone on vitreous vancomycin concentrations in patients with suspected postoperative bacterial endophthalmitis. Graefes Arch. Clin. Exp. Ophthalmol. 2005, 243:1186-1189.
76. Gan I.M., Ugahary L.C., van Dissel J.T., Feron E., Peperkamp E., Veckeneer M., Mulder P.G., Platenkamp G.J., van Meurs J.C. Intravitreal dexamethasone as adjuvant in the treatment of postoperative endophthalmitis: a prospective randomized trial. Graefes Arch. Clin. Exp. Ophthalmol. 2005, 243:1200-1205.
77. Garza-Gonzalez E., Lopez D., Pezina C., Muruet W., Bocanegra-Garcia V., Munoz I., Ramirez C., Llaca-Diaz J.M. Diversity of staphylococcal cassette chromosome mec structures in coagulase-negative staphylococci and relationship to drug resistance. J. Med. Microbiol. 2010, 59:323-329.
78. Garzozi H.J., Harris A. Intraocular lens implants and risk of endophthalmitis. Br. J. Ophthalmol. 2000, 84:554.
79. Gertz S., Engelmann S., Schmid R., Ziebandt A.K., Tischer K., Scharf C., Hacker J., Hecker M. Characterization of the sigma(B) regulon in Staphylococcus aureus. J. Bacteriol. 2000, 182:6983-6991.
80. Ghelardi E., Celandroni F., Salvetti S., Ceragioli M., Beecher D.J., Senesi S., Wong A.C. Swarming behavior of and hemolysin BL secretion by Bacillus cereus. Appl. Environ. Microbiol. 2007, 73:4089-4093.
81. Giacometti A., Cirioni O., Schimizzi A.M., Del Prete M.S., Barchiesi F., D'Errico M.M., Petrelli E., Scalise G. Epidemiology and microbiology of surgical wound infections. J. Clin. Microbiol. 2000, 38:918-922.
82. Giese M.J., Berliner J.A., Riesner A., Wagar E.A., Mondino B.J. A comparison of the early inflammatory effects of an agr-/sar- versus a wild type strain of Staphylococcus aureus in a rat model of endophthalmitis. Curr. Eye Res. 1999, 18:177-185.
83. Gilmore M.S., Haas W. The selective advantage of microbial fratricide. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:8401-8402.
84. Gilmore M.S., Cruz-Rodz A.L., Leimeister-Wachter M., Kreft J., Goebel W. A Bacillus cereus cytolytic determinant, cereolysin AB, which comprises the phospholipase C and sphingomyelinase genes: nucleotide sequence and genetic linkage. J. Bacteriol. 1989, 171:744-753.
85. Goerke C., Wolz C. Regulatory and genomic plasticity of Staphylococcus aureus during persistent colonization and infection. Int. J. Med. Microbiol. 2004, 294:195-202.
86. Gotz F. Staphylococcus and biofilms. Mol. Microbiol. 2002, 43:1367-1378.
87. Grandgirard D., Loeffler J.M., Fischetti V.A., Leib S.L. Phage lytic enzyme Cpl-1 for antibacterial therapy in experimental pneumococcal meningitis. J. Infect. Dis. 2008, 197:1519-1522.
88. Guiral S., Mitchell T.J., Martin B., Claverys J.P. Competence-programmed predation of noncompetent cells in the human pathogen Streptococcus pneumoniae: genetic requirements. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:8710-8715.
89. Gungor S.G., Akova Y.A., Bozkurt A., Yasar U., Babaoglu M.O., Cetinkaya A., Colak M. Aqueous humour penetration of moxifloxocin and gatifloxacin eye drops in different dosing regimens before phacoemulsification surgery. Br. J. Ophthalmol. 2011, 95:1272-1275.
90. Guo B., Zhao X., Shi Y., Zhu D., Zhang Y. Pathogenic implication of a fibrinogen-binding protein of Staphylococcus epidermidis in a rat model of intravascular-catheter-associated infection. Infect. Immun. 2007, 75:2991-2995.
91. Haas W., Shepard B.D., Gilmore M.S. Two-component regulator of Enterococcus faecalis cytolysin responds to quorum-sensing autoinduction. Nature 2002, 415:84-87.
92. Haas W., Pillar C.M., Torres M., Morris T.W., Sahm D.F. Monitoring antibiotic resistance in ocular microorganisms: results from the Antibiotic Resistance Monitoring in Ocular MicRorganisms (ARMOR) 2009 surveillance study. Am. J. Ophthalmol. 2011.
93. Hancock L.E., Perego M. The Enterococcus faecalis fsr two-component system controls biofilm development through production of gelatinase. J. Bacteriol. 2004, 186:5629-5639.
94. Hartford O., O'Brien L., Schofield K., Wells J., Foster T.J. The Fbe (SdrG) protein of Staphylococcus epidermidis HB promotes bacterial adherence to fibrinogen. Microbiology 2001, 147:2545-2552.
95. Hashimoto M., Tawaratsumida K., Kariya H., Kiyohara A., Suda Y., Krikae F., Kirikae T., Gotz F. Not lipoteichoic acid but lipoproteins appear to be the dominant immunobiologically active compounds in Staphylococcus aureus. J. Immunol. 2006, 177:3162-3169.
96. Havarstein L.S., Coomaraswamy G., Morrison D.A. An unmodified heptadecapeptide pheromone induces competence for genetic transformation in Streptococcus pneumoniae. Proc. Natl. Acad. Sci. U.S.A. 1995, 92:11140-11144.
97. Havarstein L.S., Diep D.B., Nes I.F. A family of bacteriocin ABC transporters carry out proteolytic processing of their substrates concomitant with export. Mol. Microbiol. 1995, 16:229-240.
98. Haynes R.J., McElveen J.E., Dua H.S., Tighe P.J., Liversidge J. Expression of human beta-defensins in intraocular tissues. Invest. Ophthalmol. Vis. Sci. 2000, 41:3026-3031.
99. Heilmann C., Hussain M., Peters G., Gotz F. Evidence for autolysin-mediated primary attachment of Staphylococcus epidermidis to a polystyrene surface. Mol. Microbiol. 1997, 24:1013-1024.
100. Hendriksen W.T., Bootsma H.J., Estevao S., Hoogenboezem T., de Jong A., de Groot R., Kuipers O.P., Hermans P.W. CodY of Streptococcus pneumoniae: link between nutritional gene regulation and colonization. J. Bacteriol. 2008, 190:590-601.
101. Hirst R.A., Gosai B., Rutman A., Guerin C.J., Nicotera P., Andrew P.W., O'Callaghan C. Streptococcus pneumoniae deficient in pneumolysin or autolysin has reduced virulence in meningitis. J. Infect. Dis. 2008, 197:744-751.
102. Holden M.T. Complete genomes of two clinical Staphylococcus aureus strains: evidence for the rapid evolution of virulence and drug resistance. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:9786-9791.
103. Howes E.L., Cole P.W., Adair T.M., Cruse V.K., Pollycove M. Cellular and vascular responses in acute experimental ocular inflammation. Invest. Ophthalmol. Vis. Sci. 1994, 35:4031-4038.
104. Huhtinen M., Puolakkainen M., Laasila K., Sarvas M., Karma A., Leirisalo-Repo M. Chlamydial antibodies in patients with previous acute anterior uveitis. Invest. Ophthalmol. Vis. Sci. 2001, 42:1816-1819.
105. Hui F.M., Zhou L., Morrison D.A. Competence for genetic transformation in Streptococcus pneumoniae: organization of a regulatory locus with homology to two lactococcin A secretion genes. Gene 1995, 153:25-31.
106. Huntzinger E. Staphylococcus aureus RNAIII and the endoribonuclease III coordinately regulate spa gene expression. EMBO J. 2005, 24:824-835.
107. Huseby M., Shi K., Brown C.K., Digre J., Mengistu F., Seo K.S., Bohach G.A., Schlievert P.M., Ohlendorf D.H., Earhart C.A. Structure and biological activities of beta toxin from Staphylococcus aureus. J. Bacteriol. 2007, 189:8719-8726.
108. Jarraud S., Lyon G.J., Figueiredo A.M., Gerard L., Vandenesch F., Etienne J., Muir T.W., Novick R.P. Exfoliatin-producing strains define a fourth agr specificity group in Staphylococcus aureus. J. Bacteriol. 2000, 182:6517-6522.
109. Jefferson K.K., Pier D.B., Goldmann D.A., Pier G.B. The teicoplanin-associated locus regulator (TcaR) and the intercellular adhesin locus regulator (IcaR) are transcriptional inhibitors of the ica locus in Staphylococcus aureus. J. Bacteriol. 2004, 186:2449-2456.
110. Jett B.D., Jensen H.G., Atkuri R.V., Gilmore M.S. Evaluation of therapeutic measures for treating endophthalmitis caused by isogenic toxin-producing and toxin-nonproducing Enterococcus faecalis strains. Invest. Ophthalmol. Vis. Sci. 1995, 36:9-15.
111. Jevons M.P., Coe A.W., Parker M.T. Methicillin resistance in staphylococci. Lancet 1963, 1:904-907.
112. Ji G., Beavis R., Novick R.P. Bacterial interference caused by autoinducing peptide variants. Science 1997, 276:2027-2030.
113. Jonas J.B., Knorr H.L., Budde W.M. Prognostic factors in ocular injuries caused by intraocular or retrobulbar foreign bodies. Ophthalmology 2000, 107:823-828.
114. Juarez-Verdayes M.A., Reyes-Lopez M.A., Cancino-Diaz M.E., Munoz-Salas S., Rodriguez-Martinez S., de la Serna F.J., Hernandez-Rodriguez C.H., Cancino-Diaz J.C. Isolation, vancomycin resistance and biofilm production of Staphylococcus epidermidis from patients with conjunctivitis, corneal ulcers, and endophthalmitis. Rev. Latinoam. Microbiol. 2006, 48:238-246.
115. Kanclerski K., Mollby R. Production and purification of Streptococcus pneumoniae hemolysin (pneumolysin). J. Clin. Microbiol. 1987, 25:222-225.
116. Katayama Y., Ito T., Hiramatsu K. A new class of genetic element, staphylococcus cassette chromosome mec, encodes methicillin resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 2000, 44:1549-1555.
117. Kattan H.M., Flynn H.W., Pflugfelder S.C., Robertson C., Forster R.K. Nosocomial endophthalmitis survey. Current incidence of infection after intraocular surgery. Ophthalmology 1991, 98:227-238.
118. Kazakova S.V. A clone of methicillin-resistant Staphylococcus aureus among professional football players. N. Engl. J. Med. 2005, 352:468-475.
119. Kim S.J., Toma H.S. Antimicrobial resistance and ophthalmic antibiotics: 1-year results of a longitudinal controlled study of patients undergoing intravitreal injections. Arch. Ophthalmol. 2011, 129:1180-1188.
120. Kinnebrew M.A., Ubeda C., Zenewicz L.A., Smith N., Flavell R.A., Pamer E.G. Bacterial flagellin stimulates Toll-like receptor 5-dependent defense against vancomycin-resistant Enterococcus infection. J. Infect. Dis. 2010, 201:534-543.
121. Klein K.S., Walsh M.K., Hassan T.S., Halperin L.S., Castellarin A.A., Roth D., Driscoll S., Prenner J.L. Endophthalmitis after anti-VEGF injections. Ophthalmology 2009, 116. 1225.e1.
122. Klevens R.M. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. J. Am. Med. Ass. 2007, 298:1763-1771.
123. Kobayakawa S., Jett B.D., Gilmore M.S. Biofilm formation by Enterococcus faecalis on intraocular lens material. Curr. Eye Res. 2005, 30:741-745.
124. Kodjikian L., Couprie J., Hachicha W., Timour Q., Devouassoux M., Builles N., Hartmann D., Fessi H. Experimental intracameral injection of vancomycin microparticles in rabbits. Invest. Ophthalmol. Vis. Sci. 2010.
125. Koizumi K., Poulaki V., Doehmen S., Welsandt G., Radetzky S., Lappas A., Kociok N., Kirchhof B., Joussen A.M. Contribution of TNF-alpha to leukocyte adhesion, vascular leakage, and apoptotic cell death in endotoxin-induced uveitis in vivo. Invest. Ophthalmol. Vis. Sci. 2003, 44:2184-2191.
126. Kong K.F., Vuong C., Otto M. Staphylococcus quorum sensing in biofilm formation and infection. Int. J. Med. Microbiol. 2006, 296:133-139.
127. Krivan H.C., Roberts D.D., Ginsburg V. Many pulmonary pathogenic bacteria bind specifically to the carbohydrate sequence GalNAc beta 1-4Gal found in some glycolipids. Proc. Natl. Acad. Sci. U.S.A. 1988, 85:6157-6161.
128. Kullik I., Giachino P., Fuchs T. Deletion of the alternative sigma factor sigmaB in Staphylococcus aureus reveals its function as a global regulator of virulence genes. J. Bacteriol. 1998, 180:4814-4820.
129. Lalwani G.A., Flynn H.W., Scott I.U., Quinn C.M., Berrocal A.M., Davis J.L., Murray T.G., Smiddy W.E., Miller D. Acute-onset endophthalmitis after clear corneal cataract surgery (1996-2005). Clinical features, causative organisms, and visual acuity outcomes. Ophthalmology 2008, 115:473-476.
130. Lamont M., Booth A. Post-traumatic endophthalmitis following penetrating injury with dental needle. Eye (Lond) 2006, 20:981-982.
131. Leng T., Miller D., Flynn H.W., Jacobs D.J., Gedde S.J. Delayed-onset bleb-associated endophthalmitis (1996-2008): causative organisms and visual acuity outcomes. Retina 2011, 31:344-352.
132. Lerner L.E., Polansky J.R., Howes E.L., Stern R. Hyaluronan in the human trabecular meshwork. Invest. Ophthalmol. Vis. Sci. 1997, 38:1222-1228.
133. Liu F., Kwok A.K., Cheung B.M. The efficacy of intravitreal vancomycin and dexamethasone in the treatment of experimental Bacillus cereus endophthalmitis. Curr. Eye Res. 2008, 33:761-768.
134. Liu C. Clinical practice guidelines by the infectious diseases society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin. Infect. Dis. 2011, 52:e18-55.
135. Mac I., Soltau J.B. Glaucoma-filtering bleb infections. Curr. Opin. Ophthalmol. 2003, 14:91-94.
136. Majerczyk C.D., Sadykov M.R., Luong T.T., Lee C., Somerville G.A., Sonenshein A.L. Staphylococcus aureus CodY negatively regulates virulence gene expression. J. Bacteriol. 2008, 190:2257-2265.
137. Majerczyk C.D., Dunman P.M., Luong T.T., Lee C.Y., Sadykov M.R., Somerville G.A., Bodi K., Sonenshein A.L. Direct targets of CodY in Staphylococcus aureus. J. Bacteriol. 2010, 192:2861-2877.
138. Major J.C., Engelbert M., Flynn H.W., Miller D., Smiddy W.E., Davis J.L. Staphylococcus aureus endophthalmitis: antibiotic susceptibilities, methicillin resistance, and clinical outcomes. Am. J. Ophthalmol. 2010, 149. 278-283.e1.
139. Manna A., Cheung A.L. Characterization of sarR, a modulator of sar expression in Staphylococcus aureus. Infect. Immun. 2001, 69:885-896.
140. Mao L.K., Flynn H.W., Miller D., Pflugfelder S.C. Endophthalmitis caused by streptococcal species. Arch. Ophthalmol. 1992, 110:798-801.
141. Marshall M.J., Bohach G.A., Boehm D.F. Characterization of Staphylococcus aureus beta-toxin induced leukotoxicity. J. Nat. Toxins 2000, 9:125-138.
142. McMenamin P.G., Crewe J., Morrison S., Holt P.G. Immunomorphologic studies of macrophages and MHC class II-positive dendritic cells in the iris and ciliary body of the rat, mouse, and human eye. Invest. Ophthalmol. Vis. Sci. 1994, 35:3234-3250.
143. Meredith T.A., Aguilar H.E., Drews C., Sawant A., Gardner S., Wilson L.A., Grossniklaus H.E. Intraocular dexamethasone produces a harmful effect on treatment of experimental Staphylococcus aureus endophthalmitis. Trans. Am. Ophthalmol. Soc. 1996, 94:241-252. Discussion 252-257.
144. Miller J.J., Scott I.U., Flynn H.W., Smiddy W.E., Newton J., Miller D. Acute-onset endophthalmitis after cataract surgery (2000-2004): incidence, clinical settings, and visual acuity outcomes after treatment. Am. J. Ophthalmol. 2005, 139:983-987.
145. Miller D., Flynn P.M., Scott I.U., Alfonso E.C., Flynn H.W. In vitro fluoroquinolone resistance in staphylococcal endophthalmitis isolates. Arch. Ophthalmol. 2006, 124:479-483.
146. Miller D.M., Vedula A.S., Flynn H.W., Miller D., Scott I.U., Smiddy W.E., Murray T.G., Venkatraman A.S. Endophthalmitis caused by Staphylococcus epidermidis: in vitro antibiotic susceptibilities and clinical outcomes. Ophthalmic Surg. Lasers Imaging 2007, 38:446-451.
147. Mino de Kaspar H., Chang R.T., Singh K., Egbert P.R., Blumenkranz M.S., Ta C.N. Prospective randomized comparison of 2 different methods of 5% povidone-iodine applications for anterior segment intraocular surgery. Arch. Ophthalmol. 2005, 123:161-165.
148. Miragaia M. Genetic diversity of arginine catabolic mobile element in Staphylococcus epidermidis. PLoS One 2009, 4:e7722.
149. Montan P.G., Wejde G., Koranyi G., Rylander M. Prophylactic intracameral cefuroxime. Efficacy in preventing endophthalmitis after cataract surgery. J. Cataract Refract. Surg. 2002, 28:977-981.
150. Moreillon P., Entenza J.M., Francioli P., McDevitt D., Foster T.J., Francois P., Vaudaux P. Role of Staphylococcus aureus coagulase and clumping factor in pathogenesis of experimental endocarditis. Infect. Immun. 1995, 63:4738-4743.
151. Morfeldt E., Janzon L., Arvidson S., Lofdahl S. Cloning of a chromosomal locus (exp) which regulates the expression of several exoprotein genes in Staphylococcus aureus. Mol. Gen. Genet. 1988, 211:435-440.
152. Morfeldt E., Taylor D., von Gabain A., Arvidson S. Activation of alpha-toxin translation in Staphylococcus aureus by the trans-encoded antisense RNA, RNAIII. EMBO J. 1995, 14:4569-4577.
153. Moss J.M., Sanislo S.R., Ta C.N. A prospective randomized evaluation of topical gatifloxacin on conjunctival flora in patients undergoing intravitreal injections. Ophthalmology 2009, 116:1498-1501.
154. Moyer A.L., Ramadan R.T., Thurman J., Burroughs A., Callegan M.C. Bacillus cereus induces permeability of an in vitro blood-retina barrier. Infect. Immun. 2008, 76:1358-1367.
155. Moyer A.L., Ramadan R.T., Novosad B.D., Astley R., Callegan M.C. Bacillus cereus-induced permeability of the blood-ocular barrier during experimental endophthalmitis. Invest. Ophthalmol. Vis. Sci. 2009, 50:3783-3793.
156. Murata M., Horiuchi S. Hyaluronan synthases, hyaluronan and its CD44 receptors in the posterior segment of rabbit eye. Ophthalmologica 2005, 219:287-291.
157. Murjaneh S., Waqar S., Hale J.E., Kasmiya M., Jacob J., Quinn A.G. National survey of the use of intraoperative antibiotics for prophylaxis against postoperative endophthalmitis following cataract surgery in the UK. Br. J. Ophthalmol. 2010, 94:1410-1411.
158. Murray B.E. Vancomycin-resistant enterococcal infections. N. Engl. J. Med. 2000, 342:710-721.
159. Nakayama J., Cao Y., Horii T., Sakuda S., Akkermans A.D., de Vos W.M., Nagasawa H. Gelatinase biosynthesis-activating pheromone: a peptide lactone that mediates a quorum sensing in Enterococcus faecalis. Mol. Microbiol. 2001, 41:145-154.
160. Nakayama J., Chen S., Oyama N., Nishiguchi K., Azab E.A., Tanaka E., Kariyama R., Sonomoto K. Revised model for Enterococcus faecalis fsr quorum-sensing system: the small open reading frame fsrD encodes the gelatinase biosynthesis-activating pheromone propeptide corresponding to staphylococcal agrd. J. Bacteriol. 2006, 188:8321-8326.
161. Nayak N. Fungal infections of the eye - laboratory diagnosis and treatment. Nepal Med. Coll. J. 2008, 10:48-63.
162. Ng E.W., Costa J.R., Samiy N., Ruoff K.L., Connolly E., Cousins F.V., D'Amico D.J. Contribution of pneumolysin and autolysin to the pathogenesis of experimental pneumococcal endophthalmitis. Retina 2002, 22:622-632.
163. Nilsson M., Frykberg L., Flock J.I., Pei L., Lindberg M., Guss B. A fibrinogen-binding protein of Staphylococcus epidermidis. Infect. Immun. 1998, 66:2666-2673.
164. Novick R.P. Autoinduction and signal transduction in the regulation of staphylococcal virulence. Mol. Microbiol. 2003, 48:1429-1449.
165. Ong-Tone L. Aqueous humor penetration of gatifloxacin and moxifloxacin eyedrops given by different methods before cataract surgery. J. Cataract Refract. Surg. 2007, 33:59-62.
166. Orihuela C.J., Mahdavi J., Thornton J., Mann B., Wooldridge K.G., Abouseada N., Oldfield N.J., Self T., Ala'Aldeen D.A., Tuomanen E.I. Laminin receptor initiates bacterial contact with the blood brain barrier in experimental meningitis models. J. Clin. Invest. 2009, 119:1638-1646.
167. Ormerod L.D., Becker L.E., Cruise R.J., Grohar H.I., Paton B.G., Frederick A.R., Topping T.M., Weiter J.J., Buzney S.M., Baker A.S. Endophthalmitis caused by the coagulase-negative staphylococci. 2. Factors influencing presentation after cataract surgery. Ophthalmology 1993, 100:724-729.
168. Otto M., Sussmuth R., Vuong C., Jung G., Gotz F. Inhibition of virulence factor expression in Staphylococcus aureus by the Staphylococcus epidermidis agr pheromone and derivatives. FEBS Lett. 1999, 450:257-262.
169. Otto M. Staphylococcus epidermidis-the 'accidental' pathogen. Nat. Rev. Microbiol. 2009, 7:555-567.
170. Palmqvist N., Patti J.M., Tarkowski A., Josefsson E. Expression of staphylococcal clumping factor A impedes macrophage phagocytosis. Microbes Infect. 2004, 6:188-195.
171. Parmar P., Salman A., Kaliamurthy J., Prasanth D.A., Thomas P.A., Jesudasan C.A. Anterior chamber contamination during phacoemulsification and manual small-incision cataract surgery. Am. J. Ophthalmol. 2006, 141:1160-1161.
172. Pastagia M., Euler C., Chahales P., Fuentes-Duculan J., Krueger J.G., Fischetti V.A. A novel chimeric lysin shows superiority to mupirocin for skin decolonization of methicillin-resistant and -sensitive Staphylococcus aureus strains. Antimicrob. Agents Chemother. 2011, 55:738-744.
173. Patel A.H., Nowlan P., Weavers E.D., Foster T. Virulence of protein A-deficient and alpha-toxin-deficient mutants of Staphylococcus aureus isolated by allele replacement. Infect. Immun. 1987, 55:3103-3110.
174. Paton J.C., Ferrante A. Inhibition of human polymorphonuclear leukocyte respiratory burst, bactericidal activity, and migration by pneumolysin. Infect. Immun. 1983, 41:1212-1216.
175. Paton J.C., Berry A.M., Lock R.A. Molecular analysis of putative pneumococcal virulence proteins. Microb. Drug Resist. 1997, 3:1-10.
176. Pelz A., Wieland K.P., Putzbach K., Hentschel P., Albert K., Gotz F. Structure and biosynthesis of staphyloxanthin from Staphylococcus aureus. J. Biol. Chem. 2005, 280:32493-32498.
177. Peng Y.J., Kau Y.C., Wen C.W., Liu K.S., Liu S.J. Solvent-free biodegradable scleral plugs providing sustained release of vancomycin, amikacin, and dexamethasone-an in vivo study. J. Biomed. Mater. Res. A 2010, 94:426-432.
178. Pestova E.V., Havarstein L.S., Morrison D.A. Regulation of competence for genetic transformation in Streptococcus pneumoniae by an auto-induced peptide pheromone and a two-component regulatory system. Mol. Microbiol. 1996, 21:853-862.
179. Petropoulos I.K., Vantzou C.V., Lamari F.N., Karamanos N.K., Anastassiou E.D., Pharmakakis N.M. Expression of TNF-alpha, IL-1beta, and IFN-gamma in Staphylococcus epidermidis slime-positive experimental endophthalmitis is closely related to clinical inflammatory scores. Graefes Arch. Clin. Exp. Ophthalmol. 2006, 244:1322-1328.
180. Peyman G.A., Lad E.M., Moshfeghi D.M. Intravitreal injection of therapeutic agents. Retina 2009, 29:875-912.
181. Pierre D.J., Tang J. Bleb associated endophthalmitis with methicillin-resistant Staphylococcus aureus. Br. J. Ophthalmol. 2010, 94:390-392.
182. Pijl B.J., Theelen T., Tilanus M.A., Rentenaar R., Crama N. Acute endophthalmitis after cataract surgery: 250 consecutive cases treated at a tertiary referral center in the Netherlands. Am. J. Ophthalmol. 2010, 149. 482-487.e1-2.
183. Pohl K., Francois P., Stenz L., Schlink F., Geiger T., Herbert S., Goerke C., Schrenzel J., Wolz C. CodY in Staphylococcus aureus: a regulatory link between metabolism and virulence gene expression. J. Bacteriol. 2009, 191:2953-2963.
184. Postma B., Poppelier M.J., van Galen J.C., Prossnitz E.R., van Strijp J.A., de Haas C.J., van Kessel K.P. Chemotaxis inhibitory protein of Staphylococcus aureus binds specifically to the C5a and formylated peptide receptor. J. Immunol. 2004, 172:6994-7001.
185. Qin X., Singh K.V., Weinstock G.M., Murray B.E. Effects of Enterococcus faecalis fsr genes on production of gelatinase and a serine protease and virulence. Infect. Immun. 2000, 68:2579-2586.
186. Raad I., Alrahwan A., Rolston K. Staphylococcus epidermidis: emerging resistance and need for alternative agents. Clin. Infect. Dis. 1998, 26:1182-1187.
187. Ramadan R.T., Ramirez R., Novosad B.D., Callegan M.C. Acute inflammation and loss of retinal architecture and function during experimental Bacillus endophthalmitis. Curr. Eye Res. 2006, 31:955-965.
188. Ramadan R.T., Moyer A.L., Callegan M.C. A role for tumor necrosis factor-alpha in experimental Bacillus cereus endophthalmitis pathogenesis. Invest. Ophthalmol. Vis. Sci. 2008, 49:4482-4489.
189. Rechtin T.M., Gillaspy A.F., Schumacher M.A., Brennan R.G., Smeltzer M.S., Hurlburt B.K. Characterization of the SarA virulence gene regulator of Staphylococcus aureus. Mol. Microbiol. 1999, 33:307-316.
190. Romero P., Mendez I., Salvat M., Fernandez J., Almena M. Intracameral cefazolin as prophylaxis against endophthalmitis in cataract surgery. J. Cataract Refract. Surg. 2006, 32:438-441.
191. Rosen S.D. Ligands for L-selectin: homing, inflammation, and beyond. Annu. Rev. Immunol. 2004, 22:129-156.
192. Rosenfeld P.J., Brown D.M., Heier J.S., Boyer D.S., Kaiser P.K., Chung C.Y., Kim R.Y., MARINA Study Group Ranibizumab for neovascular age-related macular degeneration. N. Engl. J. Med. 2006, 355:1419-1431.
193. Sampat K.M., Garg S.J. Complications of intravitreal injections. Curr. Opin. Ophthalmol. 2010, 21:178-183.
194. Schmidt K.A., Manna A.C., Gill S., Cheung A.L. SarT, a repressor of alpha-hemolysin in Staphylococcus aureus. Infect. Immun. 2001, 69:4749-4758.
195. Seles S., Lang G.E. Ocular manifestation of an infectious endocarditis. Klin. Monbl. Augenheilkd. 2007, 224:606-608.
196. Shah G.K., Stein J.D., Sharma S., Sivalingam A., Benson W.E., Regillo C.D., Brown G.C., Tasman W. Visual outcomes following the use of intravitreal steroids in the treatment of postoperative endophthalmitis. Ophthalmology 2000, 107:486-489.
197. Shamsuddin N., Kumar A. TLR2 mediates the innate response of retinal Muller glia to Staphylococcus aureus. J. Immunol. 2011, 186:7089-7097.
198. Shankar N., Coburn P., Pillar C., Haas W., Gilmore M. Enterococcal cytolysin: activities and association with other virulence traits in a pathogenicity island. Int. J. Med. Microbiol. 2004, 293:609-618.
199. Sharifi E., Porco T.C., Naseri A. Cost-effectiveness analysis of intracameral cefuroxime use for prophylaxis of endophthalmitis after cataract surgery. Ophthalmology 2009, 116. 1887-1896.e1.
200. Shirodkar A.R., Flynn H.W., Alliman K., Lalwani G.A., Alabiad C., Moshfeghi A.A., Miller D. The comparison of clinical outcomes of endophthalmitis from fluoroquinolone-resistant and susceptible bacteria. Clin. Ophthalmol. 2010, 4:211-214.
201. Singh K.P., Shau H., Gupta R.K., Kopald K., Ray P.K. Protein A potentiates lymphokine-activated killer cell induction in normal and melanoma patient lymphocytes. Immunopharmacol. Immunotoxicol. 1992, 14:73-103.
202. Sinha P., Ghosh A.K., Das T., Sa G., Ray P.K. Protein A of Staphylococcus aureus evokes Th1 type response in mice. Immunol. Lett. 1999, 67:157-165.
203. Slamti L., Lereclus D. A cell-cell signaling peptide activates the PlcR virulence regulon in bacteria of the Bacillus cereus group. EMBO J. 2002, 21:4550-4559.
204. Smith M.A., Sorenson J.A., Smith C., Miller M., Borenstein M. Effects of intravitreal dexamethasone on concentration of intravitreal vancomycin in experimental methicillin-resistant Staphylococcus epidermidis endophthalmitis. Antimicrob. Agents Chemother. 1991, 35:1298-1302.
205. Smith S.R., Kroll A.J., Lou P.L., Ryan E.A. Endogenous bacterial and fungal endophthalmitis. Int. Ophthalmol. Clin. 2007, 47:173-183.
206. Sonenshein A.L. CodY, a global regulator of stationary phase and virulence in Gram-positive bacteria. Curr. Opin. Microbiol. 2005, 8:203-207.
207. Sonenshein A.L. Control of key metabolic intersections in Bacillus subtilis. Nat. Rev. Microbiol. 2007, 5:917-927.
208. Song Z., Marzilli L., Greenlee B.M., Chen E.S., Silver R.F., Askin F.B., Teirstein A.S., Zhang Y., Cotter R.J., Moller D.R. Mycobacterial catalase-peroxidase is a tissue antigen and target of the adaptive immune response in systemic sarcoidosis. J. Exp. Med. 2005, 201:755-767.
209. Speaker M.G., Menikoff J.A. Prophylaxis of endophthalmitis with topical povidone-iodine. Ophthalmology 1991, 98:1769-1775.
210. Streilein J.W. Ocular immune privilege: therapeutic opportunities from an experiment of nature. Nat. Rev. Immunol. 2003, 3:879-889.
211. Strober W. Inside the microbial and immune labyrinth: gut microbes: friends or fiends?. Nat. Med. 2010, 16:1195-1197.
212. Suzuki T., Wada T., Kozai S., Ike Y., Gilmore M.S., Ohashi Y. Contribution of secreted proteases to the pathogenesis of postoperative Enterococcus faecalis endophthalmitis. J. Cataract Refract. Surg. 2008, 34:1776-1784.
213. Suzuki T., Campbell J., Swoboda J.G., Walker S., Gilmore M.S. Role of wall teichoic acids in Staphylococcus aureus endophthalmitis. Invest. Ophthalmol. Vis. Sci. 2011, 52:3187-3192.
214. Taban M., Behrens A., Newcomb R.L., Nobe M.Y., Saedi G., Sweet P.M., McDonnell P.J. Acute endophthalmitis following cataract surgery: a systematic review of the literature. Arch. Ophthalmol. 2005, 123:613-620.
215. Tang C.W., Cheng C.K., Lee T.S. Community-acquired bleb-related endophthalmitis caused by vancomycin-resistant enterococci. Can. J. Ophthalmol. 2007, 42:477-478.
216. Taylor A.W., Streilein J.W., Cousins S.W. Identification of alpha-melanocyte stimulating hormone as a potential immunosuppressive factor in aqueous humor. Curr. Eye Res. 1992, 11:1199-1206.
217. Taylor A.W. The immunomodulating neuropeptide alpha-melanocyte-stimulating hormone (alpha-MSH) suppresses LPS-stimulated TLR4 with IRAK-M in macrophages. J. Neuroimmunol. 2005, 162:43-50.
218. Taylor A.W. Ocular immune privilege. Eye (Lond) 2009, 23:1885-1889.
219. Tegmark K., Karlsson A., Arvidson S. Identification and characterization of SarH1, a new global regulator of virulence gene expression in Staphylococcus aureus. Mol. Microbiol. 2000, 37:398-409.
220. Tenover F.C., McDougal L.K., Goering R.V., Killgore G., Projan S.J., Patel J.B., Dunman P.M. Characterization of a strain of community-associated methicillin-resistant Staphylococcus aureus widely disseminated in the United States. J. Clin. Microbiol. 2006, 44:108-118.
221. Thomas V.C., Thurlow L.R., Boyle D., Hancock L.E. Regulation of autolysis-dependent extracellular DNA release by Enterococcus faecalis extracellular proteases influences biofilm development. J. Bacteriol. 2008, 190:5690-5698.
222. Thompson J.T., Parver L.M., Enger C.L., Mieler W.F., Liggett P.E. Infectious endophthalmitis after penetrating injuries with retained intraocular foreign bodies. National Eye Trauma System. Ophthalmology 1993, 100:1468-1474.
223. Thompson W.S., Rubsamen P.E., Flynn H.W., Schiffman J., Cousins S.W. Endophthalmitis after penetrating trauma. Risk factors and visual acuity outcomes. Ophthalmology 1995, 102:1696-1701.
224. Thurlow L.R., Thomas V.C., Narayanan S., Olson S., Fleming S.D., Hancock L.E. Gelatinase contributes to the pathogenesis of endocarditis caused by Enterococcus faecalis. Infect. Immun. 2010, 78:4936-4943.
225. Timmerman C.P., Mattsson E., Martinez-Martinez L., De Graaf L., Van Strijp J.A., Verbrugh H.A., Verhoef J., Fleer A. Induction of release of tumor necrosis factor from human monocytes by staphylococci and staphylococcal peptidoglycans. Infect. Immun. 1993, 61:4167-4172.
226. Tweten R.K. Cholesterol-dependent cytolysins, a family of versatile pore-forming toxins. Infect. Immun. 2005, 73:6199-6209.
227. Uchiyama S., Carlin A.F., Khosravi A., Weiman S., Banerjee A., Quach D., Hightower G., Mitchell T.J., Doran K.S., Nizet V. The surface-anchored NanA protein promotes pneumococcal brain endothelial cell invasion. J. Exp. Med. 2009, 206:1845-1852.
228. Van de Beek D. Corticosteroids for acute adult bacterial meningitis. Med. Mal. Infect. 2009, 39:531-538.
229. Vandersteegen K. Microbiological and molecular assessment of bacteriophage ISP for the control of Staphylococcus aureus. PLoS One 2011, 6:e24418.
230. VEGF Inhibition Study in Ocular Neovascularization (V.I.S.I.O.N.) Clinical Trial Group, D'Amico D.J., Masonson H.N., Patel M., Adamis A.P., Cunningham E.T., Guyer D.R., Katz B. Pegaptanib sodium for neovascular age-related macular degeneration: two-year safety results of the two prospective, multicenter, controlled clinical trials. Ophthalmology 2006, 113. 992-1001.e6.
231. Villari P., Sarnataro C., Iacuzio L. Molecular epidemiology of Staphylococcus epidermidis in a neonatal intensive care unit over a three-year period. J. Clin. Microbiol. 2000, 38:1740-1746.
232. Vuong C., Saenz H.L., Gotz F., Otto M. Impact of the agr quorum-sensing system on adherence to polystyrene in Staphylococcus aureus. J. Infect. Dis. 2000, 182:1688-1693.
233. Vuong C., Durr M., Carmody A.B., Peschel A., Klebanoff S.J., Otto M. Regulated expression of pathogen-associated molecular pattern molecules in Staphylococcus epidermidis: quorum-sensing determines pro-inflammatory capacity and production of phenol-soluble modulins. Cell. Microbiol. 2004, 6:753-759.
234. Wakefield D., Stahlberg T.H., Toivanen A., Granfors K., Tennant C. Serologic evidence of Yersinia infection in patients with anterior uveitis. Arch. Ophthalmol. 1990, 108:219-221.
235. Walev I., Martin E., Jonas D., Mohamadzadeh M., Muller-Klieser W., Kunz L., Bhakdi S. Staphylococcal alpha-toxin kills human keratinocytes by permeabilizing the plasma membrane for monovalent ions. Infect. Immun. 1993, 61:4972-4979.
236. Wang R. Identification of novel cytolytic peptides as key virulence determinants for community-associated MRSA. Nat. Med. 2007, 13:1510-1514.
237. Wejde G., Montan P., Lundstrom M., Stenevi U., Thorburn W. Endophthalmitis following cataract surgery in Sweden: national prospective survey 1999-2001. Acta Ophthalmol. Scand. 2005, 83:7-10.
238. West E.S., Behrens A., McDonnell P.J., Tielsch J.M., Schein O.D. The incidence of endophthalmitis after cataract surgery among the U.S. Medicare population increased between 1994 and 2001. Ophthalmology 2005, 112:1388-1394.
239. Whiston E.A., Sugi N., Kamradt M.C., Sack C., Heimer S.R., Engelbert M., Wawrousek E.F., Gilmore M.S., Ksander B.R., Gregory M.S. alphaB-crystallin protects retinal tissue during Staphylococcus aureus-induced endophthalmitis. Infect. Immun. 2008, 76:1781-1790.
240. Wiskur B.J., Robinson M.L., Farrand A.J., Novosad B.D., Callegan M.C. Toward improving therapeutic regimens for Bacillus endophthalmitis. Invest. Ophthalmol. Vis. Sci. 2008, 49:1480-1487.
241. Witzenrath M. Systemic use of the endolysin Cpl-1 rescues mice with fatal pneumococcal pneumonia. Crit. Care Med. 2009, 37:642-649.
242. Wright J.S., Jin R., Novick R.P. Transient interference with staphylococcal quorum sensing blocks abscess formation. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:1691-1696.
243. Wu P.C., Li M., Chang S.J., Teng M.C., Yow S.G., Shin S.J., Kuo H.K. Risk of endophthalmitis after cataract surgery using different protocols for povidone-iodine preoperative disinfection. J. Ocul. Pharmacol. Ther. 2006, 22:54-61.
244. Wykoff C.C., Parrott M.B., Flynn H.W., Shi W., Miller D., Alfonso E.C. Nosocomial acute-onset postoperative endophthalmitis at a university teaching hospital (2002-2009). Am. J. Ophthalmol. 2010, 150. 392-398.e2.
245. Xu K.D., McFeters G.A., Stewart P.S. Biofilm resistance to antimicrobial agents. Microbiology 2000, 146(Pt 3):547-549.
246. Yanagihori H., Oyama N., Nakamura K., Mizuki N., Oguma K., Kaneko F. Role of IL-12B promoter polymorphism in Adamantiades-Behcet's disease susceptibility: an involvement of Th1 immunoreactivity against Streptococcus Sanguinis antigen. J. Invest. Dermatol. 2006, 126:1534-1540.
247. Yarwood J.M., Bartels D.J., Volper E.M., Greenberg E.P. Quorum sensing in Staphylococcus aureus biofilms. J. Bacteriol. 2004, 186:1838-1850.
248. Yildirim O., Oz O., Aslan G., Cinel L., Delialioglu N., Kanik A. The efficacy of intravitreal levofloxacin and intravitreal dexamethasone in experimental Staphylococcus epidermidis endophthalmitis. Ophthalmic Res. 2002, 34:349-356.
249. Yoshida J., Kim A., Pratzer K.A., Stark W.J. Aqueous penetration of moxifloxacin 0.5% ophthalmic solution and besifloxacin 0.6% ophthalmic suspension in cataract surgery patients. J. Cataract Refract. Surg. 2010, 36:1499-1502.
250. Yu-Wai-Man P., Morgan S.J., Hildreth A.J., Steel D.H., Allen D. Efficacy of intracameral and subconjunctival cefuroxime in preventing endophthalmitis after cataract surgery. J. Cataract Refract. Surg. 2008, 34:447-451.
251. Zetola N., Francis J.S., Nuermberger E.L., Bishai W.R. Community-acquired meticillin-resistant Staphylococcus aureus: an emerging threat. Lancet Infect. Dis. 2005, 5:275-286.
252. Zhang K., McClure J.A., Elsayed S., Conly J.M. Novel staphylococcal cassette chromosome mec type, tentatively designated type VIII, harboring class A mec and type 4 ccr gene complexes in a Canadian epidemic strain of methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 2009, 53:531-540.